Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

JNCE Stock Annual Cash Flow. Download in Excel

Jounce Therapeutics Inc. logo

Jounce Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

1.88
 
USD
  
-0.05
  
(-2.59%)
Previous close: 1.93  Open: 1.91  Bid:   Ask:
52 week range    
0.00   
   0.00
Mkt Cap: 0 M  Avg Vol (90 Days): 0
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 9th December 2024

Stock Rankings

21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

JNCE Cash Flow

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in other current assets-266000.0-728000.0-1 M490000.0451000.0
(Increase) Decrease in other current liabilities-72 M-65 M-98 M2 M-2 M-387000.0
(Increase) Decrease in payables373000.0562000.0-944000.0-296000.0-329000.0421000.0
(Increase) Decrease in receivables17 M
Amortization1 M-1 M-1 M47000.0921000.0903000.0
CapitalExpenditureReported15 M1 M985000.094000.0373000.0919000.0
Cash at beginning of period46 M25 M49 M55 M149 M97 M
Cash at end of period25 M49 M55 M149 M97 M152 M
Cash flow-91 M-64 M-30 M-28 M-83 M-29 M
CashFlowFromContinuingInvestingActivities-38 M86 M31 M51 M-61 M83 M
ChangeInAccountPayable373000.0562000.0-944000.0-296000.0-329000.0421000.0
ChangeInAccruedExpense4 M-1 M2 M3 M1 M4 M
ChangeInInterestPayable4 M-1 M2 M3 M1 M4 M
ChangeInPayablesAndAccruedExpense4 M-881000.01 M3 M1 M4 M
ChangeInWorkingCapital-67 M-49 M-98 M3 M-516000.04 M
Depreciation4 M4 M4 M3 M3 M2 M
Depreciation unreconciled6 M3 M2 M3 M4 M3 M
DepreciationAndAmortization6 M3 M2 M3 M4 M3 M
FinancingCashFlow107 M2 M4 M71 M92 M442000.0
Free cash flow-106 M-65 M-31 M-28 M-84 M-30 M
GainLossOnSaleOfPPE75000.0-103000.0
IncomeTaxPaidSupplementalData17 M101000.045000.08000.017000.0
Issuance of capital stock107 M4 M14 M91 M
IssuanceOfCapitalStock107 M4 M14 M91 M
Net cash from financing activities107 M2 M4 M15 M92 M442000.0
Net cash from investing activities-38 M86 M31 M51 M-61 M83 M
Net cash from operating activities-91 M-64 M-30 M-28 M-83 M-29 M
Net change in cash & cash equivalents-22 M24 M5 M94 M-52 M55 M
Net income from continuing operations-16 M-27 M57 M-44 M-91 M-51 M
NetCommonStockIssuance107 M4 M14 M91 M
NetInvestmentPropertiesPurchaseAndSale-23 M88 M32 M51 M-60 M84 M
NetInvestmentPurchaseAndSale-23 M88 M32 M51 M-60 M84 M
NetPPEPurchaseAndSale-15 M-1 M-985000.0-94000.0-373000.0-919000.0
Operating (gains) losses75000.0-103000.0
Other non-cash items-13 M10 M8 M10 M4 M15 M
ProceedsFromStockOptionExercised462000.02 M437000.0600000.01 M442000.0
Purchase of Float term investments-180 M-253 M-189 M-86 M-130 M-25 M
Purchase of property plant & equipment-15 M-1 M-985000.0-94000.0-373000.0-919000.0
PurchaseOfInvestment-180 M-253 M-189 M-86 M-130 M-25 M
PurchaseOfPPE-15 M-1 M-985000.0-94000.0-373000.0-919000.0
Sale of short term investments157 M341 M221 M137 M70 M109 M
SaleOfInvestment157 M341 M221 M137 M70 M109 M
StockBasedCompensation5 M9 M10 M10 M11 M10 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University